Figure 5. Construction of the epigenetic-based prognostic risk signature in the TCGA cohort. (A) The risk score distribution of LUAD patients. (B) Survival status and duration of patients. (C) Survival curves for the low risk and high risk groups. (D) Time-independent receiver operating characteristic (ROC) analysis of risk scores for prediction the overall survival in the TCGA set.